BIOTECH TURNAROUND FUND (BTF)
Biotech Turnaround Fund (BTF) B.V. is a cross-over, turnaround venture capital operating company, focusing on building a portfolio of six late-stage biotechnology companies. Companies with several drug development candidates in phase II clinical trials.
BIOTECH TURNAROUND FUND (BTF)
Founded:
2000-01-01
Status:
Closed
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Mobile Non Scaleable Content Nginx Google Adsense AdBlock Acceptable Ads Google Adsense For Domains SEDO DNS
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2008-01-01 | Genizon BioSciences | Biotech Turnaround Fund (BTF) investment in Series E - Genizon BioSciences | 30.81 M USD |
2007-04-19 | CymaBay Therapeutics | Biotech Turnaround Fund (BTF) investment in Series D - CymaBay Therapeutics | 32 M USD |
2007-02-05 | Genizon BioSciences | Biotech Turnaround Fund (BTF) investment in Series D - Genizon BioSciences | 10 M CAD |
2003-08-29 | CymaBay Therapeutics | Biotech Turnaround Fund (BTF) investment in Series A - CymaBay Therapeutics | 27 M USD |
2003-02-25 | Genizon BioSciences | Biotech Turnaround Fund (BTF) investment in Venture Round - Genizon BioSciences | 7.7 M USD |
2001-10-12 | Genizon BioSciences | Biotech Turnaround Fund (BTF) investment in Venture Round - Genizon BioSciences | 16.5 M USD |
2001-10-10 | Galileo Genomics | Biotech Turnaround Fund (BTF) investment in Venture Round - Galileo Genomics | 16.5 M USD |